Main Article Content

Alka Maral
Pooja Gupta
Prerna Gupta
Alok Semwal


Microspheres, Gluteraldehyde, tripolyphosphate (TPP), formaldehyde (FA) Neuropathy


Tuberculosis is an infectious disease that mainly affects the lungs. For the treatment of tuberculosis conventional drug delivery system fails to achieve efficient drug delivery at the target site. Now a days Chitosan microspheres become a topic of great interest as a novel drug delivery system. Chitosan microspheres for improving  therapeutic action of drug increasing prolongs action, lowering dose frequency of dosage form and to improve patient complies. The aim of this combined study was to overcome the side effect of antitubercular drug (Isoniazid) which is neuropathy and influence of the molar mass and deacetylation degree of chitosan microspheres at the different concentration of three different cross-linking agents viz, tripolyphosphate (TPP), formaldehyde (FA) and Gluteraldehyde (GA) has been prepare by Ionotropic gelation method.The influence of these cross- linking agent on the properties of chitosan microsphers was extensively investigated. The the partical size and encapsulation efficiencies of thus preparation chitosan microspheres ranged mainly between

Areas covered This research article Isoniazid/Pyridoxin combination therapy for the treatment of tuberculosis. The reduction of side effect of Isoniazid (neuropathy) and patients compliance of Isoniazid/pyridoxine in tubercular patients are discussed based on the available literature.

Expert opinion: It was found that Isoniazid/pyridoxine combination therapy for the treatment of tuberculosis combination therapy could significantly improve bioequivalence studies. It also reduces side effect of isoniazid nuropathy.

Abstract 239 | pdf Downloads 87


1. World health organization and TB Initiative (World Organization treatment of Tuberculosis: guidelines. World health organization; 2010. 73-85.
2. Dua K, Rapalli VK, Shukla SD, Singhvi G, Shastri MD, Chellappan DK, Satija S, Mehta M, Gulati M, Pinto TD, Gupta G. Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: emerging need for novel drug delivery approaches. Biomedicine & Pharmacotherapy. 2018 Nov 1;107:1218-29.
3. D.K. Chellappan, L.W. Yee, K.Y. Xuan, K. Kunalan, L.C. Rou, L.S. Jean, L.Y Ying, L.X. Wie, J. Chellian, M. Mehta, S Satija. Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases. Drug development research. 2020 Jun;81(4):419-36.
4. J. J. Van Der Watt, T. B. Harrison M. Benatar, J. M. Heckmann*(2011). Polyneuropathy, Anti- tuberculosis treatment and the role of pyridoxine in the HIV/AIDS era: a systematic Review. International Journal tuberculosis lung disease 2015(6):722-728.
5. A. Chaudhari, K.R. Jadhav, V.J. Kadam.(2010). An Overview: Microspheres as a Nasal Drug Delivery System. Int. J. of Pharmaceutical Sciences Review and Res. 2010: 359-377.
6. B. D. Emir , K. Ebru. , B. Cengiz, O. Eylem,( 2002). magnetic chitosan microspheres: preparation and characterization .World Journal of Pharmacy and Pharmaceutical Sciences 2002.4(11), 225–232.
7. Varshosaz J. The promise of chitosan microspheres in drug delivery systems. Expert opinion on drug delivery. 2007 May 1;4(3):263-73.
8. S. Thamburu, P. Shammika., C. Sreeja. Nair*(2016). Chitosan-eudragit Magnetic Microspheres of Sulfasalazine for colon drug delivery. Int. J. of Pharmaceutical Sciences Review and Res.2016. 41(2), 125-131.
9. D. Nag,., S. Das,., & A. Samanta, (2015). Formulation and evaluation of immediate release tablets of Isoniazid and pyridoxine hydrochloride. World Journal of Pharmacy and Pharmaceutical Sciences 2015. 4(8), 1726–1740.
10. P. Y. Pawar, A.V. Lagad, S. N. Bahir, Sumedha and R. Rathi (2012). Simultaneous UV spectrophotometric method for estimation of Isoniazid and Pyridoxine in tablet dosage form. Der PharmaChemica,2012, 4(2),749-754.
11. Z. Limei, L. Ying, Z. Yun & Z. Chunyan (2016). Sustained release of Isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment. Science china life sciences; (2016) Vol.59, 724-731.
12. G.K. Desi, .H.Park, , (2005). Preparation of cross-linked chitosan microspheres by spray drying: Effect of cross-linking agent on the properties of spray dried microspheres. Journal of microencapsulation; 2005; 22(4):377-395.
13. S.P. Li, C.R. Kowalski, K.M. Feld, W.M. Grim. (2000). Recent Advances in Microencapsulation Technology and Equipment. Drug Delivery . International journal of pharmaceutics 2000. 988; 14, 353-76.
14. Z. I. Itov, S. V. Stepanova, B. S. El'yanov, V. I. Gunar, (1987). Synthesis of pyridoxine under high pressure. Khimiko-Farmatsevticheskii Zhurnal (1987), 21(7), 858-62.
15. L. A. Lachman, H.A. Liberman, J.L. Kanig. (2002). The Theory and Practice of Industrial Pharmacy. Mumbai, India: Varghese Publishing House; 2002. 414-415.
16. M. Jain, S. Choudhary, M. Islam.(2020). Formulation Evaluation and Optimization of Chitosan coated Ceftriaxone loaded micropartocles. International journal of pharmaceutical sciences and drug research; 2020. ,21(4), 29-34
17. C. Saikia, P. Gogol and Tarun K Maji* (2015). Chitosan : A Promosing Biopolymer I Drug Delivery Applications. Journal of Molecular And Genetic Medicine 2015. 15(5) 110.
18. B, Conti, T, Modena, I, Genta, P,Perugini and F,Pavanetto (2009). A Proposed new method for the Cross linking of Chitosan Microspheres. drug delieary, (2009) 5;2, 87-93
19. S. Senthil kumar , A. Kumar saha, K. Kavitha and S. Kumar basu (2012) Evaluation of clobazam loaded ionically cross-linked microspheres using chitosan. Pelagia Research Library and Der pharmacia sinica, 2012, 3(6): 616-623.
20. D. C. Quenelle , G. A. Winchester, J.K. Esther, L.W. Barrow and W.W. Barrow (2010) Antimicrobial Agent and Chemotherapy . (2010). 45 (6): 1637-1644.
21. K. G. H. Desai and H. J. Park (2015) preparation of cross- linked chitosan microspheres by ionic gelation method: Effect of cross-linking agent on the properties of spray dried microspheres .(2015) , Journal of microencapsulation, 2015, 22(4): 377-395.
22. M. Acikgoz, HS. kas, M. Orman , AA. Hincal (1996) Chitosan microspheres of diclofenac sodium: I application of factorial design and evaluation of release kinetics. Journal of microencapsulation 1996 13(2): 1414-159.
23. SH. Hosseini, J. Simiari, B. Farhadpour, S. Ben Abdessalem, I. Zbali, N. Litim, S. Mokhtar, I. Kaya, S. Koça, Ehsani M, Zeynali ME. Formulation and evaluation of chitosan microspheres by using ionic gelation method of antitumor drug.(2009). Iranian Polymer Journal. 2018. 21(12) 994.
24. M. W. Mwangi, L. J. Tirop, P. M. Njogu, J. M. Bururia, N. M. Njuguna, and E. G. Mbae. "Formulation of dispersible isoniazid/pyridoxine fixed-dose combination tablets for isoniazid preventive therapy in pediatrics." Cogent Medicine (2020): 17(8) 7694.
25. V. Shukla,, & Manvi, F. V. (2010). Effect of two different superdisintegrants on combinaion dispersible tablets of isoniazid and rifampicin for oral treatment of tuberculosis. International Journal of Drug Delivery2010. 2(4) 123-212.
26. Citrariana, Shesanthi, E. Lukitaningsih, and A. K. Nugroho. "Studi Perbandingan Disolusi In-Vitro Pada Formula Tablet Levofloksasin Immediate-Release Menggunakan Variasi Kadar Disintegran Sodium Starch Glycolate." Majalah Farmaseutik 2016. 1: 83-90.
27. G.S. Madhulika, B.R. Kuber. A review on natural and synthetic polymers employed in the formulation of oral disintegrating tablets. Journal of Drug Delivery and Therapeutics. 2019 Apr 15;9(2-s):652-8.
28. P.Y. Pawar, A.V. Lagad, S.N. Bahir, R. Rathi. Simultaneous UV spectrophotometric method for estimation of isoniazid and pyridoxine in tablet dosage form. Der Pharma Chemica. 2012;4(2).
29. D. Nag, S. Das, and A. Samanta. Formulation and evaluation of immediate release tablets of Isoniazid and pyridoxine hydrochloride. World Journal of Pharmacy and Pharmaceutical Sciences. 2015. 4(8):1726-40.
30. B. Vaghela, R. Kayastha, N. Bhatt, N. Pathak, D. Rathod. Development and validation of dissolution procedures. Journal of applied pharmaceutical science. 2011. 1(3):50-6.
31. M.P. Jayaswal. PREFORMULATION STUDIES: PHYSICOCHEMICAL CHARACTERIZATION OF NEW DRUG MOLECULES. International journal of pharmaceutics 2016. 17; 88(1):1-2.
32. N Sriram, P Katakam. Formulation and evaluation of mucoadhesive microspheres of pioglitazone hydrochloride prepared by ionotropic external gelation technique. Journal of Encapsulation and Adsorption Sciences. 2016 Mar 2;6(1):22-34.
33. Pachuau L, Sarkar S, Mazumder B. Formulation and evaluation of matrix microspheres for simultaneous delivery of salbutamol sulphate and theophylline. Tropical Journal of Pharmaceutical Research. 2008;7(2):995-1002.
34. B.S. Raj, I.S. Punitha, and J. Bodiwala. Formulation and evaluation of chitosan prazosin beads by ionotropic gelation method. International Journal Reearch, Pharm Chem. 2012. 2:974-83.
35. A.K. Anal, W. F. Stevens, C. Remunan-Lopez. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. International journal of pharmaceutics. 2006. Apr 7;312(1-2):166-73.
36. C.H. Goh, P.W. Heng, L.W. Chan. Alginates as a useful natural polymer for microencapsulation and therapeutic applications. Carbohydrate Polymers. 2012 International journal of pharmaceutics 2015. Mar 17;88(1):1-2.
37. Y.D. Reddy, V. Ravisankar, P.R. Prakash, K. Shravani, P.A. Kumar, A.B. Shravani. PREPARATION AND EVALUATION OF GLIBENCLAMIDE-ALGINATE MICROSPHERES. International journal of pharmaceutics 2019. Mar 17;56(1):1-2.

Most read articles by the same author(s)